EA023107B1 - Фармацевтическая композиция, содержащая по меньшей мере один белковый активный ингредиент, защищенный от расщепления ферментами - Google Patents

Фармацевтическая композиция, содержащая по меньшей мере один белковый активный ингредиент, защищенный от расщепления ферментами Download PDF

Info

Publication number
EA023107B1
EA023107B1 EA201070746A EA201070746A EA023107B1 EA 023107 B1 EA023107 B1 EA 023107B1 EA 201070746 A EA201070746 A EA 201070746A EA 201070746 A EA201070746 A EA 201070746A EA 023107 B1 EA023107 B1 EA 023107B1
Authority
EA
Eurasian Patent Office
Prior art keywords
insulin
active ingredient
protein active
buffer
composition according
Prior art date
Application number
EA201070746A
Other languages
English (en)
Russian (ru)
Other versions
EA201070746A1 (ru
Inventor
Фарид Беннис
Жан-Жак Серрано
Original Assignee
Фарид Беннис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фарид Беннис filed Critical Фарид Беннис
Publication of EA201070746A1 publication Critical patent/EA201070746A1/ru
Publication of EA023107B1 publication Critical patent/EA023107B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EA201070746A 2007-12-19 2008-12-18 Фармацевтическая композиция, содержащая по меньшей мере один белковый активный ингредиент, защищенный от расщепления ферментами EA023107B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0759971A FR2925333B1 (fr) 2007-12-19 2007-12-19 Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
PCT/FR2008/052357 WO2009083686A1 (fr) 2007-12-19 2008-12-18 Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives

Publications (2)

Publication Number Publication Date
EA201070746A1 EA201070746A1 (ru) 2011-02-28
EA023107B1 true EA023107B1 (ru) 2016-04-29

Family

ID=39671377

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070746A EA023107B1 (ru) 2007-12-19 2008-12-18 Фармацевтическая композиция, содержащая по меньшей мере один белковый активный ингредиент, защищенный от расщепления ферментами

Country Status (18)

Country Link
US (1) US8309123B2 (OSRAM)
EP (1) EP2234598B1 (OSRAM)
JP (1) JP5676272B2 (OSRAM)
KR (2) KR101592609B1 (OSRAM)
CN (1) CN101917967B (OSRAM)
AP (1) AP3573A (OSRAM)
AR (1) AR069847A1 (OSRAM)
AU (1) AU2008345474B2 (OSRAM)
BR (1) BRPI0821373B8 (OSRAM)
CA (1) CA2709899C (OSRAM)
EA (1) EA023107B1 (OSRAM)
FR (1) FR2925333B1 (OSRAM)
IL (1) IL206364A (OSRAM)
MA (1) MA31927B1 (OSRAM)
MX (1) MX2010006927A (OSRAM)
TN (1) TN2010000290A1 (OSRAM)
TW (1) TWI461226B (OSRAM)
WO (1) WO2009083686A1 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120035103A1 (en) * 2010-01-29 2012-02-09 Pillion Dennis J Method for administration of insulin and pharmaceutical composition thereof
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
WO2016016845A1 (en) 2014-07-30 2016-02-04 Sun Pharmaceutical Industries Limited Dual-chamber pack
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
JP2017514903A (ja) 2014-05-01 2017-06-08 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． 徐放性懸濁組成物
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
ES2759004T3 (es) 2014-11-04 2020-05-07 Innopharmax Inc Administración oral de medicamentos inestables o mal absorbidos
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
FR3120189B1 (fr) * 2021-03-01 2024-11-29 Farid Bennis Composition pharmaceutique pour une administration par voie orale d’un agoniste du récepteur du GLP-1

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2123524A1 (en) * 1971-01-28 1972-09-08 Nat Res Dev N-blocked insulin derivs - with high water solubility, and the corresp o-blocked cpds
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
WO1997033531A1 (en) * 1996-03-15 1997-09-18 Unigene Laboratories, Inc. Oral peptide pharmaceutical products
WO2001036656A2 (en) * 1999-11-15 2001-05-25 Jederstroem Gustaf A complex between hyaluronic acid and a biomolecule and its use
US20020132757A1 (en) * 2000-05-15 2002-09-19 Mccoy Randall E. Formulations for administering calcitonin and processes for preparing the same
WO2002072075A1 (en) * 2001-03-08 2002-09-19 Unigene Laboratories Inc. Oral peptide pharmaceutical dosage form and method of production
WO2007032018A1 (en) * 2005-09-15 2007-03-22 Council Of Scientific And Industrial Research pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES
US20070154559A1 (en) * 2003-12-24 2007-07-05 Chaul-Min Pai Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179904A1 (en) 1984-05-09 1986-05-07 Medaphore Inc. Oral insulin and a method of making the same
US4693433A (en) * 1986-06-06 1987-09-15 Merrill David Martin Unwind stand for web rolls
US6191105B1 (en) * 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
WO1996006632A1 (en) * 1994-09-01 1996-03-07 Allied Medical Research Associates Compositions and methods for delivery of polypeptides
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
DE69738333T2 (de) * 1997-10-01 2008-11-27 Novadel Pharma Inc. Nichtpolares Spray zur bukkalen Verabreichung
SE9801495D0 (sv) * 1998-04-28 1998-04-28 Astra Ab Protein formulationa
US6531648B1 (en) * 1998-12-17 2003-03-11 Syngenta Participations Ag Grain processing method and transgenic plants useful therein
EP1031347B1 (en) * 1999-01-27 2002-04-17 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
GB0119859D0 (en) * 2001-08-15 2001-10-10 Qinetiq Ltd Eye tracking system
US20060258561A1 (en) * 2003-03-13 2006-11-16 Novo Nordisk A/S Novel NPH insulin preparations
EP1765406A4 (en) * 2004-05-21 2012-11-28 Mediplex Corp ADDITIVES FOR IMPROVED MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
PT1773878E (pt) * 2004-07-19 2015-06-05 Biocon Ltd Conjugados de insulina-oligómero, formulaçôes e usos dos mesmos
EP2248531A1 (en) * 2004-08-03 2010-11-10 Emisphere Technologies, Inc. Antidiabetic oral insulin-biguanide combination
PL1883394T3 (pl) 2005-05-23 2018-09-28 Sdg, Inc. Konstrukt lipidowy do dostarczania insuliny ssakowi
WO2008048298A2 (en) * 2005-11-21 2008-04-24 Medivas, Llc Polymer particles for delivery of macromolecules and methods of use
WO2007121318A2 (en) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2123524A1 (en) * 1971-01-28 1972-09-08 Nat Res Dev N-blocked insulin derivs - with high water solubility, and the corresp o-blocked cpds
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
WO1997033531A1 (en) * 1996-03-15 1997-09-18 Unigene Laboratories, Inc. Oral peptide pharmaceutical products
WO2001036656A2 (en) * 1999-11-15 2001-05-25 Jederstroem Gustaf A complex between hyaluronic acid and a biomolecule and its use
US20020132757A1 (en) * 2000-05-15 2002-09-19 Mccoy Randall E. Formulations for administering calcitonin and processes for preparing the same
WO2002072075A1 (en) * 2001-03-08 2002-09-19 Unigene Laboratories Inc. Oral peptide pharmaceutical dosage form and method of production
US20030017203A1 (en) * 2001-03-08 2003-01-23 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
US20070154559A1 (en) * 2003-12-24 2007-07-05 Chaul-Min Pai Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
WO2007032018A1 (en) * 2005-09-15 2007-03-22 Council Of Scientific And Industrial Research pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES

Also Published As

Publication number Publication date
TW200940107A (en) 2009-10-01
MA31927B1 (fr) 2010-12-01
US20090176691A1 (en) 2009-07-09
JP2011506587A (ja) 2011-03-03
AP2010005298A0 (en) 2010-06-30
JP5676272B2 (ja) 2015-02-25
MX2010006927A (es) 2010-12-06
CA2709899C (fr) 2018-01-16
KR20150132887A (ko) 2015-11-26
US8309123B2 (en) 2012-11-13
IL206364A (en) 2016-12-29
KR101592609B1 (ko) 2016-02-05
TWI461226B (zh) 2014-11-21
BRPI0821373B1 (pt) 2020-04-22
CA2709899A1 (fr) 2009-07-09
TN2010000290A1 (fr) 2011-11-11
FR2925333A1 (fr) 2009-06-26
BRPI0821373A2 (pt) 2015-06-16
CN101917967A (zh) 2010-12-15
AP3573A (en) 2016-02-08
FR2925333B1 (fr) 2012-04-13
EP2234598B1 (fr) 2025-11-19
AR069847A1 (es) 2010-02-24
AU2008345474A1 (en) 2009-07-09
KR20100095449A (ko) 2010-08-30
EA201070746A1 (ru) 2011-02-28
AU2008345474B2 (en) 2014-07-31
HK1146386A1 (en) 2011-06-03
IL206364A0 (en) 2010-12-30
WO2009083686A1 (fr) 2009-07-09
EP2234598A1 (fr) 2010-10-06
WO2009083686A9 (fr) 2009-10-15
BRPI0821373B8 (pt) 2021-05-25
CN101917967B (zh) 2013-05-22

Similar Documents

Publication Publication Date Title
EA023107B1 (ru) Фармацевтическая композиция, содержащая по меньшей мере один белковый активный ингредиент, защищенный от расщепления ферментами
EP1791553B1 (en) Compositions for delivering peptide yy and pyy agonists
ES2645588T3 (es) Métodos y composiciones para la administración oral de exenatida
JP2010525033A (ja) 高濃縮のインスリン溶液及び組成物
WO2009048945A1 (en) Rapid mucosal gel or film insulin compositions
JPH0678238B2 (ja) インシュリンを含む薬剤組成物
WO2004104018A2 (en) Compositions for delivering peptide yy and pyy agonists
JP2020511478A (ja) 生理活性物質の経口送達
CN101014360A (zh) 抗糖尿病口服胰岛素－双胍组合物
US20230053812A1 (en) Stable peptide formulations for oral use
KR20020014570A (ko) 고체분산화시킨 무정형 이프리플라본의 제조방법
US20130090288A1 (en) Pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes
EP4456919A1 (en) Oral delivery
HK1146386B (en) Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
WO2025166413A1 (en) Compositions and methods for delivering glp-1 agonists (metabolix)
HK1107524B (en) Compositions for delivering peptide yy and pyy agonists
CN101668514A (zh) 高度浓缩的胰岛素溶液和组合物